Identification of a rare sulfonic acid metabolite of andrographolide in rats

Drug Metabolism and Disposition

Volumn 31, Issue 8, 2003, Pages 983-985

  He, Xiangjiu ^a   Li, Jiankuan ^a   Gao, Hao ^a   Qiu, Feng ^a   Hu, Ke ^b   Cui, Xiangmin ^c   Yao, Xinsheng ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c Pan Pacific Pharmaceutical Co Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHOLIDE; SULFONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG METABOLISM; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; URINALYSIS;

ADMINISTRATION, ORAL; ANIMALS; CARBON ISOTOPES; DITERPENES; INTESTINE, SMALL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; SULFONIC ACIDS;

ANIMALIA;

EID: 0042026296     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.8.983     Document Type: Article

References (12)

1. Amroyan E, Gabrielian E, Panossian A, Wikman G, and Wagner H (1999) Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6:27-31.
2. Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, and Standish LJ (2000) A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14:333-338.
3. Matsuda T, Kuroyanagi M, Sugiyama S, Umehara K, Ueno A, and Nishi K (1994) Cell differentiation-inducing diterpenes from Andrographis paniculata. Chem Pharm Bull 42:1216-1225.
4. Meng ZM (1981) Studies on the structure of the adduct of andrographolide with sodium hydrogen sulfite. Acta Pharmaceutica Sinica 16:571-575.
5. Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, and Wagner H (2000) Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 7:351-364.
6. Shen YC, Chen CF, and Chiou WF (2002) Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135:399-406.
7. Sinha J, Mukhopadhyay S, Das N, and Basu MK (2000) Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo. Drug Deliv 7:209-213.
8. Wikberg T and Taskinen T (1993) Identification of major metabolites of the catechol-O-methyltransferase inhibitor nitecapone in the rat and dog. Drug Metab Dispos 21:325-333.
9. Yoshino H, Matsunaga H, Kaneko H, Yoshitake A, Nakatsuka I, and Yamada H (1993) Metabolism of N-[4-chloro-2-fluoro-5-[(1-methyl-2-propynyl)oxy]pheny 1]-3,4,5,6-tetrahydrophthalimide(S-23121) in the rat: I. Identification of a new, sulphonic acid type of conjugate. Xenobiotica 23:609-619.
10. Zhang CY and Tan BK (1997) Mechanisms of cardiovascular activity of Andrographis paniculata in the anaesthetized rat. J Ethnopharmacol 56:97-101.
11. Zhang SJ and Masayoshi A (1997) Studies on the configuration of a new component from Andrographis paniculata. Chin J Med Chem 7:270-273.
12. Zhu SP and Kang BA (1981) Distribution and excretion of [35S]NaHSO3-andrographolide by autoradiography. Zhongguo Yao Li Xue Bao 2:266-269.